IDRA

Idera Pharmaceuticals News

Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Idera Pharmaceuticals Inc IDRA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.1659 3.89% 4.4259 20:00:00
Open Price Low Price High Price Close Price Prev Close
4.23 4.06 4.48 4.36 4.26
more quote information »

Recent News

Date Time Source Heading
2/12/202115:46EDGARAmended Statement of Ownership (sc 13g/a)
1/13/202108:06EDGARCurrent Report Filing (8-k)
1/11/202106:02GLOBEIdera Pharmaceuticals to Present at Upcoming Conferences
1/06/202117:04EDGARStatement of Changes in Beneficial Ownership (4)
1/06/202116:38EDGARStatement of Changes in Beneficial Ownership (4)
1/06/202116:37EDGARStatement of Changes in Beneficial Ownership (4)
1/05/202116:44EDGARStatement of Changes in Beneficial Ownership (4)
1/05/202116:41EDGARInitial Statement of Beneficial Ownership (3)
1/05/202116:16EDGARCurrent Report Filing (8-k)
12/30/202009:17EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
12/22/202018:47EDGARStatement of Changes in Beneficial Ownership (4)
12/15/202018:00EDGARStatement of Changes in Beneficial Ownership (4)
12/15/202008:16EDGARCurrent Report Filing (8-k)
12/15/202008:05GLOBEIdera Pharmaceuticals Announces $5.0 Million in Further..
11/17/202016:27GLOBEIdera Pharmaceuticals Announces Dan Soland to Join as Chief..
10/29/202016:36GLOBEIdera Pharmaceuticals Reports Third Quarter Financial..
10/05/202016:08EDGARStatement of Changes in Beneficial Ownership (4)
10/05/202016:07EDGARStatement of Changes in Beneficial Ownership (4)
10/05/202016:07EDGARStatement of Changes in Beneficial Ownership (4)
10/05/202016:06EDGARStatement of Changes in Beneficial Ownership (4)
10/05/202016:06EDGARStatement of Changes in Beneficial Ownership (4)
9/28/202008:51EDGARCurrent Report Filing (8-k)
9/28/202008:45GLOBEIdera Pharmaceuticals Announces New U.S. Patent Coverage for..
9/28/202008:30IHNWImminent Reverse Merger Brings Windfall To Rafarma..
9/15/202007:18GLOBEIdera Pharmaceuticals to Present Tilsotolimod Data at ESMO..
9/04/202019:04EDGARStatement of Changes in Beneficial Ownership (4)
9/04/202019:02EDGARStatement of Changes in Beneficial Ownership (4)
9/03/202008:37EDGARCurrent Report Filing (8-k)
9/03/202008:26EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
9/02/202017:21EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
9/02/202017:19EDGARSecurities Registration Statement (simplified Form) (s-3)
8/17/202016:31EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
8/17/202006:26EDGARNotice of Effectiveness (effect)
8/04/202017:14EDGARSecurities Registration Statement (simplified Form) (s-3)
8/04/202017:10EDGARSecurities Registration Statement (simplified Form) (s-3)
8/04/202016:32EDGARCurrent Report Filing (8-k)
8/04/202016:25EDGARQuarterly Report (10-q)
8/04/202016:10GLOBEIdera Pharmaceuticals Reports Second Quarter Financial..
7/23/202016:39EDGARStatement of Changes in Beneficial Ownership (4)
7/23/202016:38EDGARStatement of Changes in Beneficial Ownership (4)
7/23/202016:37EDGARStatement of Changes in Beneficial Ownership (4)
7/23/202016:36EDGARStatement of Changes in Beneficial Ownership (4)
7/23/202016:35EDGARStatement of Changes in Beneficial Ownership (4)
7/15/202018:17EDGARStatement of Changes in Beneficial Ownership (4)
7/15/202008:15EDGARCurrent Report Filing (8-k)
7/15/202008:05GLOBEIdera Pharmaceuticals Announces Private Placement of up to..
6/15/202016:32EDGARCurrent Report Filing (8-k)
6/12/202006:01EDGARNotice of Effectiveness (effect)
6/02/202008:34EDGARCurrent Report Filing (8-k)
6/02/202008:27EDGARSecurities Registration Statement (simplified Form) (s-3)
See more news about this stock »


Your Recent History
NASDAQ
IDRA
Idera Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.